German Accelerator Life Sciences (GALS) Partner Ada Health Expands to the US Upon Closing $47M Funding Round

German Accelerator Life SciencesAI health companion, Ada Health intensifies collaboration with German Accelerator Life Sciences (GALS) as it expands to the US. Following the successful closing of a $47M funding round, Ada will accelerate operational and partnership developments in a rapidly growing US market. The London and Berlin-based health technology company has developed a health companion and telemedicine app as well as a decision support tool for medical professionals, which launched in late 2016. With its sophisticated AI engine paired to a vast medical knowledge base, Ada has become one of the fastest growing medical apps in 2017, with over 1.5M people using Ada to assess their health. This rapid growth is reflected by the substantial $47M financial backing they secured from lead investor Access Industries, and including the AI entrepreneur behind Amazon Alexa, William Tunstall-Pedoe and Google's Chief Business Officer Philipp Schindler.

The German Accelerator Life Sciences (GALS) program, an initiative supported by the German Federal Ministry of Economic Affairs (BMWi), will advise on the development and implementation of Ada’s US market strategy with its experienced mentor team and extensive network of partners and industry experts.

"The US has become one of our fastest growing markets," said Daniel Nathrath, CEO and Founder of Ada. "Our operational expansion, along with our new team of medical advisors and collaboration with GALS, will help us identify the most effective ways to integrate our solution into the US healthcare ecosystem and maximise the impact we deliver to patients."

"Healthcare systems are under extreme pressure," added Dr. Claire Novorol, Founder and Chief Medical Officer of Ada. "There's a tremendous potential for Ada’s assessment technology to improve personalized health support and positively transform the way in which patients and doctors interact, in the US and globally."

"We believe Ada is positioned to become a leading global health management player," commented Christoph Lengauer, CEO of the German Accelerator. "GALS is excited to be collaborating with Ada on this expansion into the US. We will leverage our deep industry network and expertise to support their continued success."

"Ada has developed one of the most highly innovative and sophisticated health assessment tools on the market," commented Thomas Kiessling, GALS mentor and former Chief Product and Innovation Officer at Deutsche Telekom. "We see many potential opportunities where Ada can add value to the US life sciences industry."

Ada's personal health companion interacts with patients via a conversational interface to identify their symptoms and suggest possible causes. As a follow up, patients in the UK have the option to remotely consult with a general practitioner through Ada's Doctor Chat. The German version of the App was launched early this month and aims to follow the extended UK model in the near future.

As part of the European Union's Horizon 2020 Research and Innovation Programme (Ada2020), Ada has also developed a decision support tool for general practitioners and specialists. After years of years refining our medical content and reasoning capabilities, along with continuous learning from medical experts, Ada provides an advanced decision support system and is now able to support doctors with their diagnosis for even the most complex and rare cases.

About Ada

Ada Health is an innovative health technology company that believes everyone in the world should have access to quality, personalized health information and care. Developed by a team of doctors, scientists and engineers, Ada Health launched its conversational health companion app to empower people with personalized medical insights and identify appropriate next steps. Supported by a sophisticated AI engine and curated medical knowledge base, Ada also augments doctors by providing earlier health information and decision support. Ada's personal health companion app is available on iOS and Android and has been one of the fastest growing medical apps in 2017, ranked #1 in over 130 countries. You can find more information about Ada at www.ada.com.

About the German Accelerator Life Sciences

The German Accelerator Life Sciences (GALS) is an initiative of the German Federal Ministry for Economic Affairs and Energy (BMWi) with the goal of helping German startups and young companies succeed in the global marketplace. GALS, centrally located and highly connected in the world’s leading life sciences innovation hub in Cambridge, Massachusetts, offers support in multiple areas: from operational assistance to high end mentoring and strategic guidance by experienced industry experts and key opinion leaders.

Most Popular Now

Researchers Apply Computing Power to Tra…

Princeton researchers have developed a new computational method that increases the ability to track the spread of cancer cells from one part of the body to another. This migration of...

Philips Powers First Tele-Intensive Care…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Japan-based Showa University announced the launch of Japan's first telemedicine intensive care (eICU) program at Showa University...

Open Call SC1-DTH-10-2019-2020: Digital …

Digital solutions supporting a continuum of care across a range of health and care services can relieve the pressure on governments to provide more cost-effective health and care systems by...

AI and Radar Technologies could Help Dia…

People with diabetes could be able to monitor their blood sugar without drawing blood using a system now being developed at the University of Waterloo. In a recent study, researchers...

Research Finds Three Major Failings in s…

In the scramble to bring successful apps for the diagnosis of skin cancer to market there is a concern that a lack of testing is risking public safety, according to...

Private Healthcare Data to be Captured b…

An initiative has been launched to ensure private healthcare data is recorded in the same way as NHS data in England, with the aim of improving consistency across the system...

Rapid Zika Detection Test Uses Smartphon…

The Zika virus, which continues to cause microcephaly and other neurological complications in infants whose mothers were infected during pregnancy, remains a public health concern. Investigators from Brigham and Women's...

AAL Market and Investment Report

The AAL Market and Investment Report was commissioned by the Ambient Assisted Living Association and aims to provide a consolidated view of the existing market and investment information in Europe...

#eHID2018 eHealth Innovation Days 2018

6 - 7 September 2018, Flensburg, Germany. The 3rd eHealth Innovation Days will take place on 6 and 7 September 2018 at Flensburg University of Applied Sciences (FUAS). As a part...

St Helens Reduces Patient Mortality Risk…

NHS professionals at a North West trust have been shortlisted for the prestigious national Patient Safety Awards, following important work around rapid response for deteriorating patients. The team at St...

EDPS-IPEN Privacy by Design Contest for …

The European Data Protection Supervisor (EDPS), in partnership with the Data Protection Authorities of Austria, Ireland and Schleswig-Holstein and supported by the Internet Privacy Engineering Network (IPEN), is pleased to...

Clinically Connected Care Homes could Re…

A large-scale project led by senior nurses to improve the health of care home residents in Calderdale, Yorkshire has reduced emergency admissions by 33 per cent with the help of...